Therefore, these results indicated that low expression of CASP6 and high expression of NLRP1 promoted tumor development, and it also was associated with poor prognosis, the sensitivity of immunotherapy, and chemotherapy in CRC. Here, NLRP1 is linked to colorectal carcinoma.